Literature DB >> 12400704

Increase in the rate of L-pipecolic acid production using lat-expressing Escherichia coli by lysP and yeiE amplification.

Tadashi Fujii1, Yasuhide Aritoku, Hitosi Agematu, Hiroshi Tsunekawa.   

Abstract

Biotransformation of L-lysine (L-Lys) to L-pipecolic acid (L-PA) using lat-expressing Escherichia coli has been reported (Fujii et al., Biosci. Biotechnol. Biochem., 66, 622-627 (2002)). The rate-limiting step of this biotransformation seemes to be the transport of L-Lys into cells. To improve the L-PA production rate, we attempted to increase the rate of L-Lys uptake. E. coli BL21 carrying a plasmid with lat and lysP (pRH125) caused a 5-fold increase in the rate of L-PA production above the level of cells carrying a plasmid with lat (pRH124). Moreover, E. coli BL21 carrying a plasmid with lat, lysP, and yeiE (pRH127) caused a 6.4-fold increase in the rate of L-PA production above the level of cells carrying pRH124. Our results from RT-PCR experiments and the sequence similarity of YeiE to LysR transcriptional regulators suggest the possibility that yeiE expression induces lysP expression. The amplification of lysP, or rather both lysP and yeiE, increases the rate of L-PA production using lat-expressing E. coli.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12400704     DOI: 10.1271/bbb.66.1981

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

Review 1.  Pipecolic acid in microbes: biosynthetic routes and enzymes.

Authors:  Min He
Journal:  J Ind Microbiol Biotechnol       Date:  2006-01-18       Impact factor: 3.346

2.  Identification of ArgP and Lrp as transcriptional regulators of lysP, the gene encoding the specific lysine permease of Escherichia coli.

Authors:  Jimena Ruiz; Ina Haneburger; Kirsten Jung
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

3.  An economically and environmentally acceptable synthesis of chiral drug intermediate L-pipecolic acid from biomass-derived lysine via artificially engineered microbes.

Authors:  Jie Cheng; Yuding Huang; Le Mi; Wujiu Chen; Dan Wang; Qinhong Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-05-10       Impact factor: 3.346

4.  Inactivation of the lys7 gene, encoding saccharopine reductase in Penicillium chrysogenum, leads to accumulation of the secondary metabolite precursors piperideine-6-carboxylic acid and pipecolic acid from alpha-aminoadipic acid.

Authors:  Leopoldo Naranjo; Eva Martín de Valmaseda; Javier Casqueiro; Ricardo V Ullán; Mónica Lamas-Maceiras; Oscar Bañuelos; Juan F Martín
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

5.  Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.

Authors:  Hanxiao Ying; Sha Tao; Jing Wang; Weichao Ma; Kequan Chen; Xin Wang; Pingkai Ouyang
Journal:  Microb Cell Fact       Date:  2017-03-27       Impact factor: 5.328

6.  Overexpression of transport proteins improves the production of 5-aminovalerate from l-lysine in Escherichia coli.

Authors:  Zhong Li; Jing Xu; Tongtong Jiang; Yongsheng Ge; Pan Liu; Manman Zhang; Zhiguo Su; Chao Gao; Cuiqing Ma; Ping Xu
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

7.  Crystal structures of YeiE from Cronobacter sakazakii and the role of sulfite tolerance in gram-negative bacteria.

Authors:  Seokho Hong; Jinshil Kim; Eunshin Cho; Soohui Na; Yeon-Ji Yoo; You-Hee Cho; Sangryeol Ryu; Nam-Chul Ha
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.